Mirum Pharmaceuticals, Inc. MIRM Stock-based compensation capitalized to inventory
Stock-based compensation capitalized to inventory at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:StockBasedCompensationCapitalizedToInventory.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory?
- Mirum Pharmaceuticals, Inc. (MIRM) reported stock-based compensation capitalized to inventory of $173K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory decreased by 18.4% year-over-year, from $212K to $173K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s stock-based compensation capitalized to inventory has grown at a 16.0% compound annual growth rate (CAGR), from $441K to $688K.
- What does stock-based compensation capitalized to inventory mean?
- Reflects the portion of stock-based compensation expense that is allocated to the cost of inventory rather than being recognized immediately as an operating expense. This accounting treatment aligns with the capitalization of production costs, ensuring that equity-based awards granted to manufacturing personnel are matched against the future sale of goods. It is a key indicator of how non-cash compensation impacts the valuation of inventory assets.